Zhenchuan Song Selected Research

Calcium Dobesilate

1/2022

Pegylated liposomal doxorubicin-induced hand-foot syndrome predicted by serum metabolomic profiling and prevented by calcium dobesilate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhenchuan Song Research Topics

Disease

17	Breast Neoplasms (Breast Cancer) 12/2024 - 01/2015
10	Neoplasms (Cancer) 01/2023 - 10/2008
4	Cardiotoxicity 03/2024 - 01/2019
3	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2018
2	Hand-Foot Syndrome 01/2022 - 01/2019
2	Carcinoma (Carcinomatosis) 02/2012 - 10/2008
1	Disease Progression 01/2023
1	Type 2 Diabetes Mellitus (MODY) 11/2021
1	Congenital Heart Defects (Congenital Heart Defect) 12/2019
1	Pathologic Complete Response 09/2019
1	Lymphatic Metastasis 09/2019
1	Alopecia (Baldness) 01/2019
1	Stomatitis 01/2019
1	Anemia 01/2019
1	Vomiting 01/2019
1	Nausea 01/2019
1	Exanthema (Rash) 01/2019
1	Neutropenia 01/2019
1	Necrosis 12/2017
1	Autoimmune Diseases (Autoimmune Disease) 02/2012
1	Stomach Neoplasms (Stomach Cancer) 02/2012

Drug/Important Bio-Agent (IBA)

6	Estrogen ReceptorsIBA 01/2024 - 06/2017
5	liposomal doxorubicin (Doxil)FDA Link 03/2024 - 01/2019
3	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2024 - 01/2015
3	Trastuzumab (Herceptin)FDA Link 01/2023 - 09/2019
3	Docetaxel (Taxotere)FDA Link 01/2022 - 01/2019
3	AnthracyclinesIBA 01/2022 - 01/2015
2	Oncogene Proteins (Oncogene Protein)IBA 01/2024 - 09/2019
2	human ERBB2 proteinIBA 01/2023 - 12/2017
2	Messenger RNA (mRNA)IBA 05/2022 - 01/2015
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2017
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2019 - 01/2019
2	Progesterone Receptors (Progesterone Receptor)IBA 09/2019 - 06/2017
2	Proteins (Proteins, Gene)FDA Link 12/2017 - 01/2015
2	4-1BB Ligand (4 1BB Ligand)IBA 02/2012 - 10/2008
1	glutaminyl-peptide cyclotransferaseIBA 12/2024
1	1-dodecylpyridoxal (PLD)IBA 03/2024
1	Epirubicin (Ellence)FDA LinkGeneric 03/2024
1	abemaciclibIBA 01/2023
1	Fulvestrant (Faslodex)FDA Link 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	Capecitabine (Xeloda)FDA Link 01/2023
1	pyrotinibIBA 01/2023
1	MicroRNAs (MicroRNA)IBA 05/2022
1	pertuzumabIBA 01/2022
1	Calcium DobesilateIBA 01/2022
1	Metformin (Glucophage)FDA LinkGeneric 11/2021
1	polyethylene glycol-poly(lactide-co-glycolide)IBA 12/2019
1	Epidermal Growth Factor (EGF)IBA 09/2019
1	Transaminases (Aminotransferases)IBA 01/2019
1	ParaffinIBA 01/2018
1	Formaldehyde (Formol)FDA Link 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	huaierIBA 12/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2017
1	RNA (Ribonucleic Acid)IBA 02/2012
1	VaccinesIBA 02/2012
1	Interleukin-12 (IL 12)IBA 02/2012

Therapy/Procedure

6	Therapeutics 03/2024 - 01/2015
5	Neoadjuvant Therapy 03/2024 - 01/2019
2	Drug Therapy (Chemotherapy) 06/2017 - 01/2015
1	Catheters 01/2023
1	Injections 01/2023
1	Lab-On-A-Chip Devices 01/2023
1	Modified Radical Mastectomy (Mastectomy, Modified) 12/2017